封面
市場調查報告書
商品編碼
2023539

放射學領域人工智慧市場分析與預測(至2035年):類型、服務、技術、應用、部署狀態、最終用戶、解決方案

AI In Radiology Market Analysis and Forecast to 2035: Type, Services, Technology, Application, Deployment, End User, Solution

出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球放射學人工智慧市場預計將從2025年的320億美元成長到2035年的2,491億美元,複合年成長率(CAGR)為18.6%。在GE醫療和西門子醫療等公司在醫院和影像中心部署人工智慧解決方案的推動下,該技術的應用正在迅速擴展。使用量以分析的影像檢查數量來衡量。定價通常為每個解決方案每年1萬美元到10萬美元以上不等,具體取決於功能和規模。訂閱模式和按收費模式都很常見。影像檢查數量的增加以及對更快、更準確診斷的需求不斷成長,正在推動該技術的應用和支出成長。

在放射學人工智慧市場中,軟體佔主導地位,因為人工智慧驅動的演算法和平台構成了放射學解決方案的核心。這些軟體工具能夠實現影像的自動化分析、異常檢測和臨床決策支持,從而顯著提高診斷準確度和工作流程效率。影像資料量的不斷成長和熟練放射科醫生的短缺是推動其應用的主要因素。雖然硬體支撐著診斷成像基礎設施,服務保障著部署和維護,但由於人工智慧模型和整合能力的不斷進步,軟體仍然是主要的驅動力。

市場區隔
類型 軟體、硬體和服務
服務 綜合服務、維護服務、諮詢服務、訓練服務
科技 機器學習、深度學習、自然語言處理、電腦視覺
應用領域 腫瘤科、循環系統、神經科、肌肉骨骼系統科、呼吸系統科
實作方法 雲端部署、本地部署、混合部署
最終用戶 醫院、診斷中心、研究機構
解決方案 診斷解決方案、基於影像的診斷解決方案、工作流程解決方案

在應用領域,腫瘤學佔主導地位,這主要得益於對早期精準癌症檢測的迫切需求。人工智慧驅動的放射學解決方案被廣泛應用於腫瘤識別、疾病進展監測和治療方案製定。神經病學和心臟病學也是人工智慧的重要應用領域,人工智慧透過先進的影像分析技術輔助檢測中風和心臟病等疾病。慢性病盛行率的不斷上升以及對更快更精準診斷日益成長的需求,正在加速人工智慧在這些放射學應用領域的普及。

區域概覽

北美憑藉其先進的醫療基礎設施、高普及率的醫學影像技術以及人工智慧與臨床工作流程的深度融合,在放射學人工智慧市場佔最大佔有率。美國在該區域處於領先地位,其醫院和診斷中心廣泛使用人工智慧工具來解讀CT、MRI和X光影像。隨著領先的人工智慧醫療公司在北美市場的強大影響力以及對數位化醫療轉型的巨額投資,人工智慧的應用正在加速發展。優惠的報銷政策、高昂的醫療費用支出以及監管機構對人工智慧診斷工具的支持性核准,進一步鞏固了北美在全球放射學人工智慧市場的主導地位。

亞太地區預計將成為放射學人工智慧市場中複合年成長率最高的地區,這主要得益於醫療系統的快速數位轉型以及對高效診斷解決方案日益成長的需求。中國、印度、日本和韓國等國家正大力投資人工智慧驅動的醫療基礎設施和醫學影像技術。患者數量的增加、放射科醫生的短缺以及慢性病患病率的上升,都在推動基於人工智慧的放射學工具的應用。政府支持智慧醫院和遠距放射學發展的舉措進一步加速了市場成長。此外,全球人工智慧公司和本地Start-Ups不斷增加的投資也鞏固了亞太地區作為成長最快區域市場的地位。

主要趨勢和促進因素

對更快、更準確的診斷影像的需求日益成長。

放射學領域人工智慧市場的主要驅動力是對更快、更準確、更有效率的診斷影像解決方案日益成長的需求。 CT、MRI 和 X 光掃描所獲得的醫學影像資料量不斷增加,給放射科醫生帶來了沉重的負擔,導致診斷延誤和誤診。人工智慧驅動的放射學工具能夠幫助實現影像分析自動化,更準確地偵測異常情況,並簡化工作流程。這些技術尤其有助於腫瘤、神經系統疾病和心血管疾病的早期檢測。慢性病盛行率的上升以及對預防醫學需求的不斷成長,進一步加速了全球醫療保健系統採用基於人工智慧的放射學解決方案。

擴展人工智慧診斷平台和遠距放射診斷服務

人工智慧在放射學領域的一大機會在於人工智慧診斷平台和遠距放射學服務的擴展。人工智慧與雲端成像系統的融合,實現了即時分析和遠距離診斷,從而改善了醫療資​​源匱乏地區的就醫途徑。遠端醫療和數位化醫院的日益普及,進一步推動了對人工智慧放射學工具的需求。此外,深度學習演算法和影像識別技術的進步也提高了診斷的準確性和效率。隨著醫療服務提供者、人工智慧公司和影像設備製造商之間合作的不斷加強,預計全球市場機會將顯著成長。

目錄

第1章:摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率:成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章:細分市場分析

  • 市場規模及預測:依類型
    • 軟體
    • 硬體
    • 服務
  • 市場規模及預測:按解決方案分類
    • 診斷解決方案
    • 影像解決方案
    • 工作流程解決方案
  • 市場規模及預測:依服務分類
    • 綜合服務
    • 維護服務
    • 諮詢服務
    • 培訓服務
  • 市場規模及預測:依技術分類
    • 機器學習
    • 深度學習
    • 自然語言處理
    • 電腦視覺
  • 市場規模及預測:依應用領域分類
    • 腫瘤學
    • 循環系統
    • 神經病學
    • 肌肉骨骼系統
    • 呼吸系統
  • 市場規模及預測:依市場細分
    • 基於雲端的
    • 現場
    • 混合
  • 市場規模及預測:依最終用戶分類
    • 醫院
    • 診斷中心
    • 研究機構

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章:公司簡介

  • Siemens Healthineers
  • GE Healthcare
  • Philips Healthcare
  • IBM Watson Health
  • Zebra Medical Vision
  • Aidoc
  • Arterys
  • EnvoyAI
  • Fujifilm Holdings
  • Canon Medical Systems
  • Nuance Communications
  • iCAD
  • Riverain Technologies
  • Lunit
  • Qure.ai
  • Vuno
  • DeepMind
  • RadNet
  • Hologic
  • Butterfly Network

第9章 關於我們

簡介目錄
Product Code: GIS34515

The global AI in Radiology market is projected to grow from $32.0 billion in 2025 to $249.1 billion by 2035, at a compound annual growth rate (CAGR) of 18.6%. Adoption is growing rapidly, with increasing deployment of AI solutions across hospitals and imaging centers by companies like GE HealthCare and Siemens Healthineers. Usage is measured by the number of imaging studies analyzed. Pricing typically ranges from USD 10,000 to over USD 100,000 annually per solution, depending on features and scale. Subscription and per-scan pricing models are common. Rising imaging volumes and the need for faster, more accurate diagnostics are driving higher adoption and spending.

The Type segment in the AI in Radiology Market is dominated by software, as AI-driven algorithms and platforms form the core of radiology solutions. These software tools enable automated image analysis, anomaly detection, and clinical decision support, significantly improving diagnostic accuracy and workflow efficiency. The increasing volume of imaging data and the shortage of skilled radiologists are key factors driving adoption. While hardware supports imaging infrastructure, and services ensure implementation and maintenance, software remains the primary growth driver due to continuous advancements in AI models and integration capabilities.

Market Segmentation
TypeSoftware, Hardware, Services
ServicesIntegration Services, Maintenance Services, Consulting Services, Training Services
TechnologyMachine Learning, Deep Learning, Natural Language Processing, Computer Vision
ApplicationOncology, Cardiology, Neurology, Musculoskeletal, Respiratory
DeploymentCloud-Based, On-Premise, Hybrid
End UserHospitals, Diagnostic Centers, Research Institutes
SolutionDiagnostic Solutions, Imaging Solutions, Workflow Solutions

The Application segment is led by oncology, driven by the high demand for early and accurate cancer detection. AI-powered radiology solutions are widely used to identify tumors, monitor disease progression, and support treatment planning. Neurology and cardiology are also significant segments, where AI aids in detecting conditions such as stroke and heart disease through advanced imaging analysis. The growing prevalence of chronic diseases and the need for faster, more precise diagnostics are accelerating the adoption of AI in radiology across these application areas.

Geographical Overview

North America holds the largest market share in the AI in Radiology Market due to its advanced healthcare infrastructure, high adoption of medical imaging technologies, and strong integration of artificial intelligence in clinical workflows. The United States leads the region with widespread use of AI-powered tools in CT, MRI, and X-ray interpretation across hospitals and diagnostic centers. Strong presence of leading AI healthcare companies, combined with significant investments in digital health transformation, accelerates adoption. Favorable reimbursement structures, high healthcare expenditure, and supportive regulatory approvals for AI-based diagnostic tools further strengthen North America's dominant position in the global AI in radiology market.

Asia Pacific is expected to register the highest CAGR in the AI in Radiology Market due to rapid digitalization of healthcare systems and increasing demand for efficient diagnostic solutions. Countries such as China, India, Japan, and South Korea are investing heavily in AI-enabled healthcare infrastructure and medical imaging technologies. Rising patient populations, shortage of radiologists, and increasing prevalence of chronic diseases are driving adoption of AI-based radiology tools. Government initiatives supporting smart hospitals and tele-radiology expansion further accelerate growth. Additionally, growing investments from global AI companies and local startups are positioning Asia Pacific as the fastest-growing regional market.

Key Trends and Drivers

Rising demand for faster and more accurate diagnostic imaging

A key driver of the AI in Radiology Market is the increasing need for faster, more accurate, and efficient diagnostic imaging solutions. The growing volume of medical imaging data from CT, MRI, and X-ray scans is overwhelming radiologists, leading to delays and diagnostic errors. AI-powered radiology tools help automate image analysis, detect abnormalities with higher precision, and improve workflow efficiency. These technologies support early disease detection, particularly in oncology, neurology, and cardiovascular conditions. Rising prevalence of chronic diseases and increasing demand for preventive healthcare are further accelerating the adoption of AI-based radiology solutions across global healthcare systems.

Expansion of AI-enabled diagnostic platforms and teleradiology services

A major opportunity in the AI in Radiology Market lies in the expansion of AI-enabled diagnostic platforms and teleradiology services. The integration of artificial intelligence with cloud-based imaging systems allows real-time analysis and remote diagnosis, improving access to healthcare in underserved regions. Increasing adoption of telemedicine and digital hospitals is further driving demand for AI-powered radiology tools. Additionally, advancements in deep learning algorithms and image recognition technologies are enhancing diagnostic accuracy and efficiency. Growing collaborations between healthcare providers, AI companies, and imaging equipment manufacturers are expected to significantly expand market opportunities globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type (Software, Hardware, Services)
  • 2.2 Key Market Highlights by Solution (Diagnostic Solutions, Imaging Solutions, Workflow Solutions)
  • 2.3 Key Market Highlights by Services (Integration Services, Maintenance Services, Consulting Services, Training Services)
  • 2.4 Key Market Highlights by Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision)
  • 2.5 Key Market Highlights by Application (Oncology, Cardiology, Neurology, Musculoskeletal, Respiratory)
  • 2.6 Key Market Highlights by Deployment (Cloud-Based, On-Premise, Hybrid)
  • 2.7 Key Market Highlights by End User (Hospitals, Diagnostic Centers, Research Institutes)

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Software
    • 4.1.2 Hardware
    • 4.1.3 Services
  • 4.2 Market Size & Forecast by Solution (2020-2035)
    • 4.2.1 Diagnostic Solutions
    • 4.2.2 Imaging Solutions
    • 4.2.3 Workflow Solutions
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Integration Services
    • 4.3.2 Maintenance Services
    • 4.3.3 Consulting Services
    • 4.3.4 Training Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Machine Learning
    • 4.4.2 Deep Learning
    • 4.4.3 Natural Language Processing
    • 4.4.4 Computer Vision
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Oncology
    • 4.5.2 Cardiology
    • 4.5.3 Neurology
    • 4.5.4 Musculoskeletal
    • 4.5.5 Respiratory
  • 4.6 Market Size & Forecast by Deployment (2020-2035)
    • 4.6.1 Cloud-Based
    • 4.6.2 On-Premise
    • 4.6.3 Hybrid
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Diagnostic Centers
    • 4.7.3 Research Institutes

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Solution
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Deployment
      • 5.2.1.7 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Solution
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Deployment
      • 5.2.2.7 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Solution
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Deployment
      • 5.2.3.7 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Solution
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Deployment
      • 5.3.1.7 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Solution
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Deployment
      • 5.3.2.7 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Solution
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Deployment
      • 5.3.3.7 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Solution
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Deployment
      • 5.4.1.7 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Solution
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Deployment
      • 5.4.2.7 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Solution
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Deployment
      • 5.4.3.7 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Solution
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Deployment
      • 5.4.4.7 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Solution
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Deployment
      • 5.4.5.7 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Solution
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Deployment
      • 5.4.6.7 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Solution
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Deployment
      • 5.4.7.7 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Solution
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Deployment
      • 5.5.1.7 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Solution
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Deployment
      • 5.5.2.7 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Solution
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Deployment
      • 5.5.3.7 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Solution
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Deployment
      • 5.5.4.7 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Solution
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Deployment
      • 5.5.5.7 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Solution
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Deployment
      • 5.5.6.7 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Solution
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Deployment
      • 5.6.1.7 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Solution
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Deployment
      • 5.6.2.7 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Solution
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Deployment
      • 5.6.3.7 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Solution
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Deployment
      • 5.6.4.7 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Solution
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Deployment
      • 5.6.5.7 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Siemens Healthineers
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 GE Healthcare
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Philips Healthcare
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 IBM Watson Health
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Zebra Medical Vision
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Aidoc
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Arterys
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 EnvoyAI
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Fujifilm Holdings
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Canon Medical Systems
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Nuance Communications
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 iCAD
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Riverain Technologies
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Lunit
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Qure.ai
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Vuno
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 DeepMind
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 RadNet
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Hologic
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Butterfly Network
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us